Non-calcium-containing phosphate binders: comparing efficacy, safety, and other clinical effects

Nephron. Clinical Practice
João M Frazão, Teresa Adragão

Abstract

Phosphate-binder therapy for hyperphosphataemia is key to the treatment of patients with chronic kidney disease (CKD)-mineral and bone disorder (MBD). Calcium-free phosphate binders are increasingly favoured since calcium-based agents potentially cause harmful calcium overload and vascular calcification that confound the benefits of reducing serum phosphorus. Several calcium-free phosphate binders are available, including the non-absorbed agent sevelamer and the absorbed agents, e.g. lanthanum and magnesium salts. Randomised controlled studies consistently show that sevelamer and lanthanum carbonate offer equivalent lowering of serum phosphorus and often effectively achieve phosphorus targets versus calcium salts, with sevelamer having a positive effect on bone disease, vascular calcification, and patient-level outcomes in dialysis patients in several trials. There is also evidence that lanthanum carbonate can improve bone health, but data are limited to its effects to vascular calcification or patient-level outcomes. Magnesium salts have also been shown to reduce serum phosphorus levels, but clear evidence is lacking on bone, vascular, or clinical outcomes. It also remains to be established whether long-term systemic accumulat...Continue Reading

References

May 1, 1991·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·M EmmettM B Cleveland
Jan 1, 1988·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·P MorinièreD Roche
Dec 1, 1973·The Journal of Clinical Investigation·A C Alfrey, N L Miller
Jan 1, 1996·Kidney International·J A DelmezE Slatopolsky
Feb 13, 2001·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·E SlatopolskyA Dusso
Jun 26, 2002·Kidney International·Glenn M ChertowUNKNOWN Treat to Goal Working Group
Dec 24, 2004·Journal of the American Society of Nephrology : JASN·Bryan KestenbaumDennis L Andress
Feb 11, 2005·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Fouad Al-BaajAlastair J Hutchison
Apr 13, 2005·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Paolo RaggiGlenn M Chertow
Jun 3, 2005·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Hans-Gernot AsmusJürgen Bommer
Aug 4, 2005·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Johann Braun
Oct 15, 2005·Nephron. Clinical Practice·Alastair J HutchisonAndre Vosskühler
Dec 1, 2005·Kidney International·Eduardo SlatopolskyJane Finch
Apr 6, 2006·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Goce B SpasovskiPatrick C D'Haese
Mar 21, 2007·Contributions to Nephrology·Eiji TakedaYutaka Taketani
Apr 26, 2007·Kidney International·P M Price
May 23, 2007·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Nora VoormolenUNKNOWN PREPARE study group
Sep 28, 2007·International Urology and Nephrology·Goce B Spasovski
Nov 1, 2007·Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation·David M SpiegelMichel Chonchol
Nov 9, 2007·Kidney International·F J MendozaE Aguilera-Tejero
Nov 10, 2007·American Journal of Nephrology·Ronney ShantoufKamyar Kalantar-Zadeh
Nov 21, 2007·Journal of Clinical Pharmacy and Therapeutics·A M BorzeckiL E Kazis
Dec 7, 2007·Clinical Journal of the American Society of Nephrology : CJASN·Kayser CaglarPeter Stenvinkel
Dec 20, 2007·Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation·Wadi N Suki, UNKNOWN Dialysis Clinical Outcomes Revisited Investigators
Jan 15, 2008·International Urology and Nephrology·Ioannis P TzanakisDimitrios G Oreopoulos
Jan 18, 2008·Journal of the American Society of Nephrology : JASN·Aníbal FerreiraUNKNOWN Sevelamer Study Group
Apr 18, 2008·Journal of the American Society of Nephrology : JASN·Suresh MathewKeith A Hruska
Apr 22, 2008·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Wajeh QunibiUNKNOWN CARE-2 Investigators
May 3, 2008·Clinical Journal of the American Society of Nephrology : CJASN·Markus KettelerPhilip A Kalra
Jun 24, 2008·International Urology and Nephrology·Faruk TurgutAdrian Covic
Jun 26, 2008·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Alastair J HutchisonUNKNOWN SPD405-313 Lanthanum Study Group
Jun 27, 2008·Clinical Journal of the American Society of Nephrology : CJASN·Rajnish MehrotraUNKNOWN Fosrenol Overview Research Evaluation Study for Early Experience Study Group
Jul 16, 2008·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Jürgen Floege
Aug 1, 2008·Nephron. Clinical Practice·Alastair J HutchisonUNKNOWN SPD405-309 Lanthanum Study Group
Sep 30, 2008·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Pieter EvenepoelStanley Fan

❮ Previous
Next ❯

Citations

Dec 5, 2013·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Francesco LocatelliGiuseppe Pontoriero
Sep 23, 2014·Expert Opinion on Investigational Drugs·Valeria CernaroMichele Buemi
Aug 2, 2016·Nephrology·Alastair J HutchisonJohn Brian Copley
May 15, 2013·Current Opinion in Nephrology and Hypertension·Joanne MarksRobert J Unwin
Nov 22, 2017·Clinical and Experimental Nephrology·Eleonora RiccioAntonio Pisani
Jul 21, 2017·Basic & Clinical Pharmacology & Toxicology·Wander Barros do CarmoHelady Sanders-Pinheiro

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.